Key terms

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest DHR news

Today 2:06am ET Buy Rating on Danaher: Strong Biotech Performance and Growth Potential Despite Market Challenges Apr 24 9:23am ET Danaher price target raised to $270 from $258 at BofA Apr 24 7:22am ET Danaher price target raised to $290 from $280 at TD Cowen Apr 24 7:20am ET Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR) Apr 24 6:46am ET RBC Capital Sticks to Its Buy Rating for Danaher (DHR) Apr 24 6:40am ET Danaher price target raised to $271 from $259 at Baird Apr 24 6:32am ET Danaher price target raised to $290 from $280 at Citi Apr 24 5:28am ET Danaher price target raised to $270 from $260 at Barclays Apr 24 4:50am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Danaher (DHR) and Roche Holding AG (OtherRHHVF) Apr 23 9:56am ET Early notable gainers among liquid option names on April 23rd Apr 23 9:41am ET Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Neurocrine (NBIX) and Medtronic (MDT) Apr 23 6:06am ET Danaher sees FY24 revenue down low-single digits, consensus $24.05B Apr 23 6:05am ET Danaher sees Q2 revenue down mid-single digits, consensus $5.73B Apr 23 6:04am ET Danaher reports Q1 adjusted EPS $1.92, consensus $1.71 Apr 22 8:25pm ET Notable companies reporting before tomorrow’s open Apr 22 1:26pm ET Notable companies reporting before tomorrow’s open Apr 19 12:26pm ET Danaher call volume above normal and directionally bullish Apr 18 9:45pm ET RBC Capital Reaffirms Their Buy Rating on Danaher (DHR) Apr 18 11:17am ET D.R. Horton Stock (NYSE:DHI): Build Your Portfolio from the Ground Up Apr 17 9:43am ET Amazon, Apple initiated: Wall Street’s top analyst calls Apr 17 9:41am ET Unusually active option classes on open April 17th Apr 17 6:50am ET HSBC upgrades Danaher to Buy on biotech funding recovery Apr 16 6:18pm ET Danaher upgraded to Buy from Hold at HSBC Apr 08 9:46pm ET RBC Capital Reaffirms Their Buy Rating on Danaher (DHR) Apr 01 4:22pm ET Danaher files automatic mixed securities shelf Mar 27 3:36pm ET Danaher put volume heavy and directionally bearish Mar 25 2:05pm ET Ingersoll-Rand’s Dover deal not a threat to bioprocessing space, says KeyBanc Mar 15 9:39am ET China stimulus positive for GE HealthCare, tool companies, says Evercore ISI Feb 14 5:12pm ET Third Point buys McKesson, exits T-Mobile in Q4 Jan 31 9:46am ET Danaher price target raised to $282 from $254 at RBC Capital Jan 31 9:37am ET Danaher price target raised to $270 from $250 at Deutsche Bank

No recent press releases are available for DHR

DHR Financials

1-year income & revenue

Key terms

DHR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

DHR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms